Back to Search
Start Over
Supplementary Table S1 from Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor–Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Adverse events of any grade and any causality.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....ecc0879185b86c87d7a81cff97c779d7